Iovance Biotherapeutics (IOVA) News
NASDAQ: IOVAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
14.62+1.31 (+9.84%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
IOVA news summary
We found 2 recent headlines mentioning Iovance Biotherapeutics (IOVA): 1 in the past week and 2 in the past 30 days, most often from Nasdaq. IOVA is making an outsized move today, up 9.84% at $14.62, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Iovance Biotherapeutics headlines
- How to Boost Your Portfolio with Top Medical Stocks Set to Beat EarningsFinding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.NasdaqIOVA, GILD
- Biotech ETFs to Buy as Cancer Drug Breakthroughs AccelerateBiotech ETFs offer diversified exposure to oncology innovation as cancer funding surges and the global oncology drug market expands.NasdaqAMGN, ILMN, MRNA, HALO